Date & Time
Monday, April 11, 2022, 5:00 PM - 6:15 PM
Plenary Session: Prevalent Infectious Disease in Corrections: HIV, HCV, COVID-19

The prevalence of HIV in 2015 for incarcerated individuals was markedly higher than the 0.4% HIV prevalence in the general United States population. In addition, HCV infection disproportionately affects individuals in correctional institutions. Along with these two diseases, COVID-19 has affected corrections in rates greatly exceeding those in the community. Individuals with serious underlying medical conditions are at greater risk of severe illness from COVID-19. Given these disproportionate numbers, it is critical that correctional health professionals have the best information on screening, treatment, and prevention of HIV, HCV, and COVID-19.

Educational objectives

  • Explain why correctional populations have higher rates of HIV, HCV, and COVID-19
  • Identify comorbidities between HIV, HCV, and COVID-19 and areas of highest concern
  • Discuss screening, testing, and treatment for HIV, HCV, and COVID-


Sponsored by an independent educational grant from Gilead Sciences

1 hour of CE. Refreshments and hors d'oeuvres will be served.